The government did not disclose financial terms of the deal, its first vaccine purchase, which will provide enough doses to vaccinate 750,000 people. Officials said talks were continuing with other drug companies to secure more vaccine supplies for the country of 5 million people and further announcements were expected next month. "The additional agreements will ensure that once the portfolio is completed, we will have sufficient COVID-19 vaccines for the whole population," Research Minister Megan Woods said in a statement. The Pfizer-BioNTech vaccine is one of the leading candidates in the race to be the first to get regulatory approval in the United States and Europe. Read also: India needs ramping up cold chain facilities for safe delivery of COVID vaccines, says Experts